-
Je něco špatně v tomto záznamu ?
Expanding the Molecular Spectrum of Carcinoma Ex Pleomorphic Adenoma: An Analysis of 84 Cases With a Novel HMGA2::LINC02389 Fusion
RA. de Lima-Souza, A. Altemani, M. Michal, FV. Mariano, I. Leivo, A. Skálová
Jazyk angličtina
Typ dokumentu časopisecké články
- MeSH
- dospělí MeSH
- fúze genů * MeSH
- genetická predispozice k nemoci MeSH
- hybridizace in situ fluorescenční MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádorové biomarkery * genetika MeSH
- nádory slinných žláz * genetika patologie MeSH
- pleomorfní adenom * genetika patologie MeSH
- protein HMGA2 * genetika MeSH
- registrace MeSH
- retrospektivní studie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- vysoce účinné nukleotidové sekvenování MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Carcinoma ex pleomorphic adenoma (CXPA) is an aggressive epithelial and/or myoepithelial neoplasm that arises in association with a pleomorphic adenoma (PA). Its etiopathogenesis remains poorly understood, but it is believed that the development of this tumor is due to the accumulation of genetic, protein, metabolic, and epigenetic alterations in a PA. A retrospective review of the Salivary Gland Tumor Registry in Pilsen yielded 84 CXPA, namely 25/84 salivary duct carcinoma (SDC), 15/84 myoepithelial carcinoma (MC), 1/84 epithelial-myoepithelial carcinoma (EMC), and 1/84 adenoid cystic carcinoma (AdCC). All 84 CXPA cases were analyzed by next-generation sequencing (NGS) and/or fluorescence in situ hybridization (FISH). Forty-three tumors originally diagnosed as CXPA (43/84, 51.2%) showed some molecular alteration. Fusion transcripts were identified in 12/16 (75%) CXPA, including LIFR::PLAG1, CTNNB1::PLAG1, FGFR1::PLAG1 , and a novel fusion, HMGA2::LINC02389 . Most of the fusions were confirmed by FISH using PLAG1 (6/11) and HMGA2 (1/1) gene break probes. Split signals indicating gene break were identified by FISH for PLAG1 (12/17), HMGA2 (3/4), EWSR1 (7/22), and MYB (2/7). Concerning pathogenic mutations, only CXPA with epithelial differentiation (SDC) presented these alterations, including HRAS mutation (2/4), TP53 (1/4), PTEN (1/4), and ATK1 (1/4). In addition, amplifications in ERBB2 (17/35), MDM2 (1/4), and EWSR1 (1/7) were detected. A novel finding was the discovery of an HMGA2::LINC02389 fusion in 1 patient with EMC ex-PA. The present results indicate that molecular profiling of CXPA with myoepithelial differentiation (MC) tends to reveal chromosomal fusion events, whereas CXPA with epithelial differentiation (SDC) tends to have a higher frequency of pathogenic mutations and gene amplifications.
Department of Oral Diagnosis Piracicaba Dental School University of Campinas Piracicaba
Department of Pathology Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic
Department of Pathology Institute of Biomedicine University of Turku Turku Finland
Department of Pathology School of Medical Sciences University of Campinas Campinas São Paulo Brazil
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25016448
- 003
- CZ-PrNML
- 005
- 20250731092917.0
- 007
- ta
- 008
- 250708s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/PAS.0000000000002307 $2 doi
- 035 __
- $a (PubMed)39324957
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a x
- 100 1_
- $a de Lima-Souza, Reydson Alcides $u Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba $u Department of Pathology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, São Paulo, Brazil $1 https://orcid.org/0000000150456960
- 245 10
- $a Expanding the Molecular Spectrum of Carcinoma Ex Pleomorphic Adenoma: An Analysis of 84 Cases With a Novel HMGA2::LINC02389 Fusion / $c RA. de Lima-Souza, A. Altemani, M. Michal, FV. Mariano, I. Leivo, A. Skálová
- 520 9_
- $a Carcinoma ex pleomorphic adenoma (CXPA) is an aggressive epithelial and/or myoepithelial neoplasm that arises in association with a pleomorphic adenoma (PA). Its etiopathogenesis remains poorly understood, but it is believed that the development of this tumor is due to the accumulation of genetic, protein, metabolic, and epigenetic alterations in a PA. A retrospective review of the Salivary Gland Tumor Registry in Pilsen yielded 84 CXPA, namely 25/84 salivary duct carcinoma (SDC), 15/84 myoepithelial carcinoma (MC), 1/84 epithelial-myoepithelial carcinoma (EMC), and 1/84 adenoid cystic carcinoma (AdCC). All 84 CXPA cases were analyzed by next-generation sequencing (NGS) and/or fluorescence in situ hybridization (FISH). Forty-three tumors originally diagnosed as CXPA (43/84, 51.2%) showed some molecular alteration. Fusion transcripts were identified in 12/16 (75%) CXPA, including LIFR::PLAG1, CTNNB1::PLAG1, FGFR1::PLAG1 , and a novel fusion, HMGA2::LINC02389 . Most of the fusions were confirmed by FISH using PLAG1 (6/11) and HMGA2 (1/1) gene break probes. Split signals indicating gene break were identified by FISH for PLAG1 (12/17), HMGA2 (3/4), EWSR1 (7/22), and MYB (2/7). Concerning pathogenic mutations, only CXPA with epithelial differentiation (SDC) presented these alterations, including HRAS mutation (2/4), TP53 (1/4), PTEN (1/4), and ATK1 (1/4). In addition, amplifications in ERBB2 (17/35), MDM2 (1/4), and EWSR1 (1/7) were detected. A novel finding was the discovery of an HMGA2::LINC02389 fusion in 1 patient with EMC ex-PA. The present results indicate that molecular profiling of CXPA with myoepithelial differentiation (MC) tends to reveal chromosomal fusion events, whereas CXPA with epithelial differentiation (SDC) tends to have a higher frequency of pathogenic mutations and gene amplifications.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nádory slinných žláz $x genetika $x patologie $7 D012468
- 650 12
- $a protein HMGA2 $x genetika $7 D025743
- 650 12
- $a pleomorfní adenom $x genetika $x patologie $7 D008949
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a nádorové biomarkery $x genetika $7 D014408
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a hybridizace in situ fluorescenční $7 D017404
- 650 12
- $a fúze genů $7 D050939
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a vysoce účinné nukleotidové sekvenování $7 D059014
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a registrace $7 D012042
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Altemani, Albina $u Department of Pathology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, São Paulo, Brazil $1 https://orcid.org/0000000299449734
- 700 1_
- $a Michal, Michal $u Bioptic Laboratory Ltd $u Department of Pathology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
- 700 1_
- $a Mariano, Fernanda Viviane $u Department of Pathology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, São Paulo, Brazil $1 https://orcid.org/0000000336945025
- 700 1_
- $a Leivo, Ilmo $u Department of Pathology, Institute of Biomedicine, University of Turku, Turku, Finland
- 700 1_
- $a Skálová, Alena $u Bioptic Laboratory Ltd $u Department of Pathology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
- 773 0_
- $w MED00000304 $t The American journal of surgical pathology $x 1532-0979 $g Roč. 48, č. 12 (2024), s. 1491-1502
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39324957 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731092912 $b ABA008
- 999 __
- $a ok $b bmc $g 2366947 $s 1253573
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 48 $c 12 $d 1491-1502 $e 20240926 $i 1532-0979 $m The American journal of surgical pathology $n Am J Surg Pathol $x MED00000304
- LZP __
- $a Pubmed-20250708
